FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products
FDA’s New Enforcement Policy: A Win for Remote Patient Monitoring and Remote Therapeutic Monitoring Manufacturers
FDA Issues New Warning Regarding Compounded Ketamine
Clinical Trials: Consent Process Clarified in New FDA Final Guidance
Gender Affirming Care in Florida: Current Rules of the Road
Gender Affirming Care Restricted Under Missouri Bill
FDA and SAMHSA Issue Joint Statement in Support of Reducing Barriers to Evidence Based Treatments
Florida’s Bill Targeting Gender Affirming Care Impacts Minors and Adults
FDA Publishes Framework for Digital Health Technologies in Clinical Trials
Subscribe: Subscribe via RSS